Purdue Pharma asserts patent infringement claims under Hatch-Waxman Act related to OxyContin® against Accord Healthcare
Client(s) Purdue Pharma L.P.
Jones Day represents plaintiffs Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. ("Purdue") in a patent litigation under the Hatch-Waxman Act in the District of Delaware. Purdue has asserted infringement of two patents related to reformulated OxyContin®.
Purdue Pharma L.P. et al. v. Accord Healthcare Inc., No. 1:22-cv-00913 (D. Del.)